ContractLicensing Agreement • September 15th, 2017 • Nightstar Therapeutics LTD • Biological products, (no disgnostic substances)
Contract Type FiledSeptember 15th, 2017 Company Industry[*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
ContractLicensing Agreement • August 31st, 2017 • Nightstar Therapeutics LTD • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledAugust 31st, 2017 Company Industry Jurisdiction[*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
ContractLicensing Agreement • August 28th, 2017 • Nightstar Therapeutics LTD • Biological products, (no disgnostic substances)
Contract Type FiledAugust 28th, 2017 Company Industry[*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.